H
H

Heineken

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

UBS cuts Remy, Diageo, Carlsberg on weak fundamentals, ups Anheuser

BUZZ-UBS cuts Remy, Diageo, Carlsberg on weak fundamentals, ups Anheuser ** Brokerage UBS holds a negative outlook on the short-term prospects of European beverages on the back of volume declines, moderating prices, and cautious management guidance for 2024 ** Volumes will only see a positive inflection from Q2 with weak spirits trends in the US persisting into the first half of the year - UBS ** "We prefer companies already delivering or at an inflection on broad-based market share gains whilst
D
H
R
A
D
P

3i Group, Phoenix, Zealand Pharma

EUROPE RESEARCH ROUNDUP- 3i Group, Phoenix, Zealand Pharma Dec 6 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including 3i Group, Phoenix, and Zealand Pharma, on Wednesday. HIGHLIGHTS * 3i Group III.L : RBC initiates coverage with outperform rating; target price 2,550p * H&M HMb.ST : Deutsche Bank cuts to sell from hold * Phoenix PHNX.L : JP Morgan raises target price to 415p from 400p * Tesco TSCO.L : Bernstein raises target price to 330p
3
A
C
C
C
D
D
E
F
H
I
K
L
M
P
R
A
H
A
D
N
P

DS Smith, Frontier Developments, IMCD NV

EUROPE RESEARCH ROUNDUP-DS Smith, Frontier Developments, IMCD NV Dec 4 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including DS Smith, Frontier Developments Plc and IMCD NV, on Monday. HIGHLIGHTS * DS Smith SMDS.L : Barclays raises to overweight from equal-weight * Frontier Developments Plc FDEV.L : Jefferies cuts to hold from buy * IMCD NV IMCD.AS : JP Morgan cuts to underweight from neutral * Proximus NV PROX.BR : JP Morgan raises to ov
A
A
A
B
B
B
B
C
D
E
F
F
G
H
K
K
N
P
R
S
S
S
U
U
A
A
A
R

JPM sees further earnings normalisation in 2024 for European consumer staples

BUZZ-JPM sees further earnings normalisation in 2024 for European consumer staples ** J.P.Morgan sees European consumer staples on course for further normalisation of financial performance into 2024 seeing the sector's defensive and compounding EPS growth as appealing ** It expects the sector to deliver about 8% EPS growth in 2024 with strong diver
B
B
D
D
G
H
J
L
N
R
S
A
C
D

India's United Breweries extends gains on bets of new beer brand's success

BUZZ-India's United Breweries extends gains on bets of new beer brand's success ** Shares of United Breweries UBBW.NS rise 2% to 1,643.90 rupees apiece, extending gains into a second straight session ** Co launched Heineken Silver Draught Beer in India on Tuesday ** Stock up about 4% between Tuesday and Wednesday ** Nuvama Institutional Equities re
H

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.